Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Orchestra BioMed Holdings Inc., 3 years.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | Orchestra BioMed Holdings Inc. | Grant or award | +17,327 | — | — |
| Aug 7, 2025 | Orchestra BioMed Holdings Inc. | Grant or award | +15,000 | — | — |
| Jun 24, 2025 | Orchestra BioMed Holdings Inc. | Grant or award | +12,422 | — | — |
| Nov 26, 2024 | Pyxis Oncology Inc. | Open-market purchase | +5,450 | $2.00 | $10,900 |
| Nov 26, 2024 | Pyxis Oncology Inc. | Open-market purchase | +83,400 | $1.96 | $163,464 |
| Jun 20, 2024 | Orchestra BioMed Holdings Inc. | Grant or award | +5,376 | — | — |
| Mar 26, 2024 | Pyxis Oncology Inc. | Grant or award | +328,710 | — | — |
| Nov 29, 2023 | Pyxis Oncology Inc. | Shares withheld for tax | −36,949 | $1.40 | $51,729 |
| Sep 28, 2023 | Pyxis Oncology Inc. | Open-market purchase | +8,000 | $1.87 | $14,960 |
| Sep 27, 2023 | Pyxis Oncology Inc. | Open-market purchase | +6,426 | $1.85 | $11,888 |
| Sep 25, 2023 | Pyxis Oncology Inc. | Open-market purchase | +12,000 | $1.67 | $20,040 |
| Sep 22, 2023 | Pyxis Oncology Inc. | Open-market purchase | +5,000 | $1.74 | $8,700 |
| Sep 7, 2023 | Pyxis Oncology Inc. | Grant or award | +187,793 | — | — |
| Jul 20, 2023 | Orchestra BioMed Holdings Inc. | Grant or award | +11,667 | — | — |
| Apr 12, 2023 | Orchestra BioMed Holdings Inc. | Option exercise | +758 | — | — |
Questions about Connealy Pamela Yanchik
What boards is Connealy Pamela Yanchik on?
Connealy Pamela Yanchik sits on the board of Orchestra BioMed Holdings Inc.
How long has Connealy Pamela Yanchik served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.